This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Pazoo, Inc. Set To Release First Pet Max Product: OxyMax H20

CEDAR KNOLLS, N.J., Jan. 15, 2013 /PRNewswire/ -- Pazoo, Inc. (OTCBB Symbol: PZOO (German WKN#: A1J3DK)) is pleased to announce that its Pet Max line of products for pets is set to be released ahead of schedule.  The first Pet Max product, the OxyMax H20, will be distributed to the largest private pet store chain in New England, Pet Life Stores, within the next 45 days. Pazoo expects to announce the release of 3 to 4 additional products from the Pet Max line by the second quarter of 2013.

OxyMax H20 is a physician formulated liquid containing oxygen that is easily dispensed through an eye dropper.  The liquid is mixed with an animal's everyday water and increases its energy by increasing the levels of oxygen in its blood.  OxyMax H20 also helps clean an animal's gums and teeth.  OxyMax H20 is safe for everyday use and has no known side effects.  Please see the product picture below as well as the label and ingredients.

(Logo: )

President of Pet Life, Pete Risano, said, "Here at Pet Life we are both honored and excited to be the first chain of stores to receive the Pet Max - OxyMax H2O and are looking forward to a long partnership with Pet Max."

CEO of Pazoo, Inc., David Cunic, said, "We are very excited about the release of OxyMax H20.  After the last several road shows and radio interviews, the buzz and the inquiries about our Pet Max line of products has been extremely positive.  We expect the OxyMax H20 product to be the start of many more successful products to come.  Here at Pazoo, we are all looking forward to getting the PetMax line in stores throughout the nation."

About Pazoo, Inc.:

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,698.18 -77.94 -0.44%
S&P 500 2,059.69 -8.20 -0.40%
NASDAQ 4,880.2280 -20.6570 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs